{"id": "1372465306648580097", "creation": 1616056202.0, "user_id": "31002593", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "In a 5-month study, 23 of 717 placebo recipients developed mild-to-moderate #COVID19 while 19 of 750 #vaccine recipients did, showing an efficacy rate of 22% in protecting against mild-to-moderate #Disease in #SouthAfrica.\n\nMORE HERE https://t.co/n0IXpuTP08\n\n#AstraZeneca #Oxford", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#DISEASE", "#SOUTHAFRICA", "#ASTRAZENECA", "#OXFORD"]}